In Vivo Cytosolic Delivery of Biomolecules into Neurons for Super‐Resolution Imaging and Genome Modification
Abstract
Efficient delivery of biomolecules into neurons has significant impacts on therapeutic applications in the central nervous system (CNS) and fundamental neuroscience research. Existing viral and non-viral delivery methods often suffer from inefficient intracellular access due to the endocytic pathway. Here, a neuron-targeting and direct cytosolic delivery platform is discovered by using a 15-amino-acid peptide, termed the N1 peptide, which enables neuron-specific targeting and cytosolic delivery of functional biomolecules. The N1 peptide initially binds hyaluronan in the extracellular matrix and subsequently passes the membrane of neurons without being trapped into endosome. This mechanism facilitates the efficient delivery of cell-impermeable and photo-stable fluorescent dye for super-resolution imaging of dendritic spines, and functional proteins, such as Cre recombinase, for site-specific genome modification. Importantly, the N1 peptide exhibits robust neuronal specificity across diverse species, including mice, rats, tree shrews, and zebra finches. Its targeting capability is further demonstrated through various administration routes, including intraparenchymal, intrathecal, and intravenous (i.v.) injections after blood-brain barrier (BBB) opening with focused ultrasound (FUS). These findings establish the N1 peptide as a versatile and functional platform with significant potential for bioimaging and advanced therapeutic applications.
Copyright and License
© 2025 The Author(s). Advanced Science published by Wiley-VCH GmbH. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Acknowledgement
This study was sponsored by Cancer Prevention and Research Institute of Texas (CPRIT) grants RP190278 and RP210236, Department of Defense grant W81XWH-21-1-0219 and American Heart Association grant 19CSLOI34770004, National Science Foundation (NSF) under grant number 2123971, National Institutes of Health (NIH) under grant numbers RF1NS110499 and R01MH140482, and Eugene McDermott Professorship at the University of Texas at Dallas. Schematic images were obtained from Biorender.com.
Contributions
X.G. and Z.Q. generated the idea, and X.G. performed most of the experiments and analyzed data. W.J. and S.M. did treeshrew experiments. S.E. and J.-M.A. synthesized and purified peptides. W.B. and L.C. did zebra finch and electrophysiology experiments. W.T. and O.Y. helped with data analysis and design experiments. S.S. and G.M. did focused ultrasound experiments. D.R., A.A., H.D., and W.B. helped immunostaining. T.Z. helped the STED imaging. X.G. drafted the manuscript. Z.Q., S.M., O.Y., and L.C. revised the manuscript. All authors contributed to the writing of this paper.
Supplemental Material
Supporting information: advs12016-sup-0001-SuppMat.docx
Files
Name | Size | Download all |
---|---|---|
md5:3b0624a8c84ab3e5d9d5d3ffdaef7250
|
37.2 MB | Download |
md5:6bd55136a63e05886522e4b90201adbb
|
8.9 MB | Preview Download |
Additional details
- Cancer Prevention and Research Institute of Texas
- RP190278
- Cancer Prevention and Research Institute of Texas
- RP210236
- United States Department of Defense
- W81XWH‐21‐1‐0219
- American Heart Association
- 19CSLOI34770004
- National Science Foundation
- 2123971
- National Institutes of Health
- RF1NS110499
- National Institutes of Health
- R01MH140482
- Available
-
2025-04-26Version of record online
- Caltech groups
- Division of Chemistry and Chemical Engineering (CCE), Division of Biology and Biological Engineering (BBE)
- Publication Status
- In Press